A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations
Titel:
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations
Auteur:
Bertoglio, Federico Fühner, Viola Ruschig, Maximilian Heine, Philip Alexander Abassi, Leila Klünemann, Thomas Rand, Ulfert Meier, Doris Langreder, Nora Steinke, Stephan Ballmann, Rico Schneider, Kai-Thomas Roth, Kristian Daniel Ralph Kuhn, Philipp Riese, Peggy Schäckermann, Dorina Korn, Janin Koch, Allan Chaudhry, M. Zeeshan Eschke, Kathrin Kim, Yeonsu Zock-Emmenthal, Susanne Becker, Marlies Scholz, Margitta Moreira, Gustavo Marçal Schmidt Garcia Wenzel, Esther Veronika Russo, Giulio Garritsen, Hendrikus S.P. Casu, Sebastian Gerstner, Andreas Roth, Günter Adler, Julia Trimpert, Jakob Hermann, Andreas Schirrmann, Thomas Dübel, Stefan Frenzel, André Van den Heuvel, Joop Čičin-Šain, Luka Schubert, Maren Hust, Michael